Classification and differential metabolite discovery of liver diseases based on plasma metabolic profiling and support vector machines (scientific article published on September 15, 2011)

Application of a metabolomic method combining one-dimensional and two-dimensional gas chromatography-time-of-flight/mass spectrometry to metabolic phenotyping of natural variants in rice

Q63313578

Metabolite profiling: from diagnostics to systems biology

Q80513306

Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry

Q84488443

A comparative study of amino acid measurement in leaf extracts by gas chromatography-time of flight-mass spectrometry and high performance liquid chromatography with fluorescence detection

Q113188794

Computational protein biomarker prediction: a case study for prostate cancer

Q24797501

XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification

Q29616057

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Q29616866

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

Q29784220

High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses

Q31002172

Dimension reduction-based penalized logistic regression for cancer classification using microarray data

Q31067105

MSVM-RFE: extensions of SVM-RFE for multiclass gene selection on DNA microarray data

Q31112287

Construction and application of a mass spectral and retention time index database generated from plant GC/EI-TOF-MS metabolite profiles

Q31131841

Prediction of mucin-type O-glycosylation sites in mammalian proteins using the composition of k-spaced amino acid pairs

Q33320216

Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol

Q33769607

Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine

Q34649328

Regulation of stearoyl-CoA desaturases and role in metabolism

Q35599793

New frontiers in biomarkers for hepatocellular carcinoma.

Q36510468

A review of feature selection techniques in bioinformatics

Q36919689

Approaches to dimensionality reduction in proteomic biomarker studies

Q37098223

Penalized feature selection and classification in bioinformatics

Q37194229

Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers

Q37734427

The metabolic switch and its regulation in cancer cells.

Q37785870

Significance analysis of functional categories in gene expression studies: a structured permutation approach

Q38521075

Aspects of amino acid and protein metabolism in cancer-bearing states

Q39845435

Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).

Q39907905

A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry

Q42627630

Noninvasive urinary metabonomic diagnosis of human bladder cancer.

Q43118946

Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population.

Q43228011

Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations

Q43283025

Gas chromatography/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients

Q43292654

Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus

Q45387926

Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.

Q45925784

Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis.

Q45996755

Integrated GC-MS and LC-MS plasma metabonomics analysis of ankylosing spondylitis

Q46425202

Progressive peak clustering in GC-MS Metabolomic experiments applied to Leishmania parasites.

Q48454701

A comparative study of feature selection and multiclass classification methods for tissue classification based on gene expression

Q50915311

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

support vector machine

vector-borne disease

metabolic profiling

page(s)

3029-3036

P577

publication date

2011-09-15

P1433

published in

Journal of Separation Science

Q15761632

P1476

title

Classification and differential metabolite discovery of liver diseases based on plasma metabolic profiling and support vector machines

P478

volume

Reverse relations

cites work (P2860)

Q48713844	A Novel and Practical Chromatographic "Fingerprint-ROC-SVM" Strategy Applied to Quality Analysis of Traditional Chinese Medicine Injections: Using KuDieZi Injection as a Case Study.
Q40092878	A Systematic Strategy for Screening and Application of Specific Biomarkers in Hepatotoxicity Using Metabolomics Combined With ROC Curves and SVMs
Q84534756	Analysis of Urinary Metabolic Signatures of Early Hepatocellular Carcinoma Recurrence after Surgical Removal Using Gas Chromatography–Mass Spectrometry
Q53290783	Expanded metabolomics approach to profiling endogenous carbohydrates in the serum of ovarian cancer patients
Q64120446	Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma
Q46503631	Lipid profiling of cyanobacteria Synechococcus sp. PCC 7002 using two-dimensional liquid chromatography with quadrupole time-of-flight mass spectrometry
Q50540296	Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery
Q92642416	Metabolomic Characterization of Human Model of Liver Rejection Identifies Aberrancies Linked to Cyclooxygenase (COX) and Nitric Oxide Synthase (NOS)
Q26741550	Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases
Q35785514	Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort
Q38696814	Metabolomics combined with pattern recognition and bioinformatics analysis methods for the development of pharmacodynamic biomarkers on liver fibrosis.
Q38103592	Metabolomics for tumor marker discovery and identification based on chromatography–mass spectrometry
Q34444673	NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review
Q37304708	Targeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC‐MS/MS
Q33893457	The metabolomic window into hepatobiliary disease

P356	DOI	10.1002/JSSC.201100408
P953	full work available at URL	https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjssc.201100408
		https://onlinelibrary.wiley.com/doi/full/10.1002/jssc.201100408
P698	PubMed publication ID	21919198